Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

July 20, 2022

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry

News Daily News

Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry

June 08, 2022

June 2022 News Roundup

News Opinion CV Team Dispatch

June 2022 News Roundup

June 01, 2022

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

April 2022 News Roundup

News Opinion CV Team Dispatch

April 2022 News Roundup

April 01, 2022

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.